CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing
Open accessAbstract
The development of a method for genome editing based on CRISPR–Cas9 technology was awarded The Nobel Prize in Chemistry in 2020, less than a decade after the discovery of all principal molecular components of the system. For the first time in history a Nobel prize was awarded to two women, Emmanuelle Charpentier and Jennifer Doudna, who made key discoveries in the field of DNA manipulation with the CRISPR–Cas9 system, so-called "genetic scissors". It is difficult to overestimate the importance of the technique as it enables one not only to manipulate genomes of model organisms in scientific experiments, and modify characteristics of important crops and animals, but also has the potential of introducing revolutionary changes in medicine, especially in treatment of genetic diseases. The original biological function of CRISPR–Cas9 system is the protection of prokaryotes from mobile genetic elements, in particular viruses. Currently, CRISPR–Cas9 and related technologies have been successfully used to cure life-threatening diseases, make coronavirus detection tests, and even to modify human embryo cells with the consequent birth of babies carrying the introduced modifications. This intervention with human germplasm cells resulted in wide disapproval in the scientific community due to ethical concerns, and calls for a moratorium on inheritable genomic manipulations. This review focuses on the history of the discovery of the CRISPR–Cas9 system with some aspects of its current applications, including ethical concerns about its use in humans.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · see citing works
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · see citing works
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · see citing works
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 6,304 · see citing works
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937 · see citing works
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769 · see citing works
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P., Dickman, M. J., Makarova, K. S., Koonin, E. V., & John van der, O. O. S. T. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,593 · see citing works
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563 · see citing works
Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5429-5433.1987 · Cited by 2,421 · see citing works
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Станиславович, М. Л., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,328 · see citing works
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Makarova, K. S., Wolf, Y. I., Iranzo, J., Shmakov, S., Alkhnbashi, O. S., Brouns, S. J. J., Charpentier, E., Cheng, D. R., Haft, D. H., Horvath, P., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0299-x · Cited by 2,328 · see citing works
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · see citing works
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements
Mojica, F. J. M., D�ez-Villase�or, C., Garc�a-Mart�nez, J., & Soria, E. (2005) · Journal of Molecular Evolution · doi:10.1007/s00239-004-0046-3 · Cited by 2,219 · see citing works
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098 · see citing works
RNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093 · see citing works
Identification of genes that are associated with DNA repeats in prokaryotes
Jansen, R., van Embden, J. D. A., Gaastra, W., & Schouls, L. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02839.x · Cited by 2,035 · see citing works
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863 · see citing works
CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA
Marraffini, L. A., & Sontheimer, E. J. (2008) · Science · doi:10.1126/science.1165771 · Cited by 1,752 · see citing works
Bolotin, A., Quinquis, B., Sorokin, A., & Ehrlich, S. D. (2005) · Microbiology · doi:10.1099/mic.0.28048-0 · Cited by 1,733 · see citing works
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
Mojica, F. J. M., Díez‐Villaseñor, C., García‐Martínez, J., & Almendros, C. (2009) · Microbiology · doi:10.1099/mic.0.023960-0 · Cited by 1,500 · see citing works
Diversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423 · see citing works
Pourcel, C., Salvignol, G., & Vergnaud, G. (2005) · Microbiology · doi:10.1099/mic.0.27437-0 · Cited by 1,347 · see citing works
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230 · see citing works
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Станиславович, М. Л., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,221 · see citing works
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J., Xie, X., Chen, Y., Li, Y., et al. (2015) · Protein & Cell · doi:10.1007/s13238-015-0153-5 · Cited by 1,135 · see citing works
Diversity and evolution of class 2 CRISPR–Cas systems
Shmakov, S., Smargon, A. A., Scott, D. A., Cox, D. B. T., Pyzocha, N., Yan, W. X., Abudayyeh, O. O., Gootenberg, J. S., Makarova, K. S., Wolf, Y. I., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.184 · Cited by 1,056 · see citing works
Mojica, F. J. M., Díez‐Villaseñor, C., Soria, E., & Juez, G. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01838.x · Cited by 821 · see citing works
A prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P. R., Botchan, M. R., Carroll, D., Charo, R. A., Church, G. M., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M. W., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 711 · see citing works
Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage
Jiang, F., Taylor, D. W., Chen, J. S., Kornfeld, J. E., Zhou, K., Thompson, A. J., Nogales, E., & Doudna, J. A. (2016) · Science · doi:10.1126/science.aad8282 · Cited by 616 · see citing works
Don’t edit the human germ line
Lanphier, E., Urnov, F., Haecker, S. E., Werner, M., & Smolenski, J. (2015) · Nature · doi:10.1038/519410a · Cited by 530 · see citing works
Origins and evolution of CRISPR-Cas systems
Koonin, E. V., & Makarova, K. S. (2019) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2018.0087 · Cited by 494 · see citing works
CRISPR gene-editing tested in a person for the first time
Cyranoski, D. (2016) · Nature · doi:10.1038/nature.2016.20988 · Cited by 442 · see citing works
Groenen, P. M. A., Bunschoten, A. E., van Soolingen, D., & van Errtbden, J. D. A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00976.x · Cited by 436 · see citing works
Makarova, K. S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.2.482 · Cited by 401 · see citing works
Next-generation diagnostics with CRISPR
Chertow, D. S. (2018) · Science · doi:10.1126/science.aat4982 · Cited by 370 · see citing works
Mojica, F. J. M., Juez, G., & Rodríguez‐Valera, F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01721.x · Cited by 364 · see citing works
A New Class of Medicines through DNA Editing
Porteus, M. H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1800729 · Cited by 229 · see citing works
The basic building blocks and evolution of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130038 · Cited by 185 · see citing works
Shmakov, S., Makarova, K. S., Wolf, Y. I., Severinov, K., & Koonin, E. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803440115 · Cited by 157 · see citing works
Human Germline and Heritable Genome Editing: The Global Policy Landscape
Baylis, F., Darnovsky, M., Hasson, K., & Krahn, T. M. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0082 · Cited by 155 · see citing works
CRISPR treatment inserted directly into the body for first time
Ledford, H. K. (2020) · Nature · doi:10.1038/d41586-020-00655-8 · Cited by 145 · see citing works
The biotech death of Jesse Gelsinger.
Stolberg, S. G. (1999) · PubMed · Cited by 144 · see citing works
First AAV gene therapy poised for landmark approval
Smalley, E. (2017) · Nature Biotechnology · doi:10.1038/nbt1117-998 · Cited by 121 · see citing works
Rapid Molecular Genetic Subtyping of Serotype M1 Group A Streptococcus Strains
Hoe, N. P., Nakashima, K., Grigsby, D., Pan, X., Dou, S. J., Naidich, S., Garcia, M., Kahn, E. B., Bergmire‐Sweat, D., & Musser, J. M. (1999) · Emerging infectious diseases · doi:10.3201/eid0502.990210 · Cited by 117 · see citing works
He, J., & Deem, M. W. (2010) · Physical Review Letters · doi:10.1103/physrevlett.105.128102 · Cited by 71 · see citing works
Microbial Arsenal of Antiviral Defenses – Part I
Isaev, A. B., Musharova, O. S., & Severinov, K. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921030081 · Cited by 57 · see citing works
Masepohl, B., Görlitz, K., & Böhme, H. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00040-1 · Cited by 55 · see citing works
Embryo editing sparks epic debate
Cyranoski, D., & Reardon, S. (2015) · Nature · doi:10.1038/520593a · Cited by 55 · see citing works
Russian biologist plans more CRISPR-edited babies
Cyranoski, D. (2019) · Nature · doi:10.1038/d41586-019-01770-x · Cited by 52 · see citing works
Microbial Arsenal of Antiviral Defenses. Part II
Isaev, A. B., Musharova, O. S., & Severinov, K. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921040064 · Cited by 51 · see citing works
Low-dimensional clustering detects incipient dominant influenza strain clusters
He, J., & Deem, M. W. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq078 · Cited by 32 · see citing works
Cyranoski, D. (2019) · Nature · doi:10.1038/d41586-019-03018-0 · Cited by 29 · see citing works
Gene therapy’s next installment
(2019) · Nature Biotechnology · doi:10.1038/s41587-019-0194-z · Cited by 26 · see citing works
Flamand, M. C., Goblet, J.-P., Duc, G., Briquet, M., & Boutry, M. (1992) · Plant Molecular Biology · doi:10.1007/bf00040524 · Cited by 24 · see citing works
Kirksey, E. (2021) · Bristol University Press eBooks · doi:10.2307/j.ctv2ws53cp · Cited by 12 · see citing works
Embattled Russian scientist sharpens plans to create gene-edited babies
(2021) · AAAS Articles DO Group · doi:10.1126/science.aaz9337 · Cited by 10 · see citing works
The CRISPR babies controversy: Responsibility and regulation in the spotlight
Meyer, M. (2020) · EMBO Reports · doi:10.15252/embr.202050307 · Cited by 8 · see citing works
Do mitochondria have an immune system?
Popkov, V. A., Zorova, L. D., Korvigo, I. O., Silachev, D. N., Jankauskas, S. S., Babenko, V. А., Pevzner, I. B., Danilina, T. I., Zorov, S. D., Plotnikov, E. Y., et al. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916100217 · Cited by 6 · see citing works
The efficacy of CRISPR-Cas9-mediated induction of the CCR5delta32 mutation in the human embryo
Кодылева, Т. А., Kirillova, A., Tyschik, E. A., Makarov, V. V., Хромов, А. В., Guschin, V. A., Abubakirov, A., Rebrikov, D. V., & Sukhikh, G. T. (2018) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2018.052 · Cited by 6 · see citing works
Neanderthal-like ‘mini-brains’ created in lab with CRISPR
Remmel, A. (2021) · Nature · doi:10.1038/d41586-021-00388-2 · Cited by 4 · see citing works
Direct Genomics revives Helicos sequencing system for China's hospitals
Cyranoski, D. (2016) · Nature Biotechnology · doi:10.1038/nbt0216-122b · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Regalado, A. (2019) China’s CRISPR babies: read exclusive excerpts from the unseen original research, MIT Technology Review. Biotechnology.
- Regalado, A. (2019) Why the paper on the CRISPR babies stayed secret for so long, MIT Technology Review. Biotechnology.
- Regalado, A. (2022) The creator of the CRISPR babies has been released from a Chinese prison, MIT Technology Review. Biotechnology.
Cited by
Still being checked.
- Authors
- Gostimskaya, I.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Gostimskaya, Irina
- Venue
- Biochemistry (Moscow)
- Publisher
- Pleiades Publishing Ltd
- Published
- 2022-08
- Volume
- 87
- Issue
- 8
- Pages
- 777-788
- ISSN
- 0006-2979 (ISSN-L)
- 1608-3040
- PMC
- PMC9377665
- OpenAlex
- W4291808634
- Cited by
- 224
- References
- 61
- Citations by year
- 2026: 54 · 2025: 73 · 2024: 61 · 2023: 34 · 2020: 1
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochemistry (Moscow) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- CRISPR/Cas9, genome editing, Emmanuelle Charpentier, Jennifer Doudna, mobile genetic elements, germline modification, ethics of gene editing, coronavirus detection
- MeSH terms
- Gene Editing, Animals, Female, Humans, Viruses, Genomics, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
